Immune Design Corp. (NASDAQ:IMDZ)
Immune Design Corp. (NASDAQ:IMDZ) Performance Snapshot
Immune Design Corp. (NASDAQ:IMDZ) Price Insight
Pfizer, Inc. (NYSE:PFE)
Pfizer, Inc. (NYSE:PFE), closed the last trading session at $36.32 with increase of $0.280000000000001 or 0.78 percent against the opening price of $36.04. The trading day volume of the company stands at 62.66 Million shares while the average trading volume of Pfizer, Inc. (NYSE:PFE) is 31.12 Million over the course of 3 consecutive months. Which signifies a pretty good change over the time with its shares outstanding of 5.56 Billion.
The price target of Pfizer, Inc. (NYSE:PFE) is currently set at 41.88 by the analysts. The stock is $-8.73 Below its 1-Year High which is $39.79. PFE hit its 1-Year low price of $26.42. The company is currently rated by analyst who are keeping a close eye on the stock as 2.6. Where 1 means Buy, 2.5 meaning Hold and 5 as Sell.
Performance Indicators of Pfizer, Inc. (NYSE:PFE)
The value of the stock decreased by -0.45% during the previous week performance. Looking at the 1 month performance of Pfizer, Inc. (NYSE:PFE), the stock jumped 2.23%. While the 1 year performance shows a positive percentage of 1.77 and year to date performance stands at -2.18%.
Pfizer, Inc. (NYSE:PFE) Analytical Review
The stock needs to grow about $5.56 to reach its price target. In order to seek the stock’s directional movements, 20-Days, 50 Days and 200-Days moving averages are 2.93%, 4.01% and 6.35 percent respectively. The stock trades about 0.83 percent of its Float giving its total shares Outstanding are 5.56 Billion. PFE gained about 2.86 percent in 6 months showing its Average True Range of 1.3. The company currently has a RSI and Beta of 55.66 and 0.65.
While talking about Pfizer, Inc. (NYSE:PFE) valuation ratios, the stock trades with a P/S and P/B of 4.03 and 3.09 which is significantly better and attractive as compared to its peers.